APLS Form 144 for sale of 10,186 shares

A Form 144 notice was filed covering a planned sale of 10,186 shares of common stock, with an aggregate market value of $225,998.82.

Rhea-AI Filing Summary

A Form 144 notice was filed covering a planned sale of 10,186 shares of common stock, with an aggregate market value of $225,998.82. The shares are to be sold through Fidelity Brokerage Services LLC on the NASDAQ, with an approximate sale date of 01/13/2026. The securities relate to an issuer with 126,525,218 shares outstanding. The seller acquired these shares on 01/12/2026 through restricted stock vesting from the issuer as compensation.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the APLS Form 144 filing disclose?

The filing discloses a planned sale of 10,186 shares of common stock with an aggregate market value of $225,998.82 under Rule 144.

How many APLS shares are planned to be sold under this Form 144?

The notice covers a proposed sale of 10,186 shares of common stock.

What is the aggregate market value of the APLS shares in this Form 144?

The aggregate market value of the shares covered by the notice is $225,998.82.

When were the APLS shares acquired and how?

The 10,186 common shares were acquired on 01/12/2026 via restricted stock vesting from the issuer as compensation.

On which exchange and around what date are the APLS shares expected to be sold?

The shares are expected to be sold on the NASDAQ around 01/13/2026.

How many shares of the issuer are outstanding in this APLS Form 144?

The issuer has 126,525,218 shares of common stock outstanding, as stated in the notice.

Who is the broker for the planned APLS Form 144 sale?

The planned sale is to be executed through Fidelity Brokerage Services LLC at 900 Salem Street, Smithfield, RI 02917.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 01/13/2026 - 03:45 PM EST Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001658080
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Apellis Pharmaceuticals, Inc.
SEC File Number	001-38276
Address of Issuer	100 FIFTH AVENUE WALTHAM MASSACHUSETTS 02451
Phone	617-977-5700
Name of Person for Whose Account the Securities are To Be Sold	Francois Cedric
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	10186	225998.82	126525218	01/13/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	01/12/2026	Restricted Stock Vesting	Issuer			10186	01/12/2026	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks	Sale includes an amount necessary to cover a tax obligation resulting from the settlement of a vested equity award distribution.
Date of Notice	01/13/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Jennifer Ruchti, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Cedric G. Francois
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)